Cholesterol drives plaque formation in Alzheimer’s disease

Credit: Unsplash+

Alzheimer’s disease is a debilitating condition that affects millions of people worldwide.

While it’s known that sticky protein buildup in the brain, called amyloid beta plaques, is a hallmark of the disease, the precise factors contributing to their formation have been a subject of intense research.

Recent findings from the University of Virginia School of Medicine shed light on a surprising culprit: cholesterol produced in the brain.

Cholesterol’s Multiple Roles

Cholesterol often gets a bad rap due to its association with clogged arteries and heart disease. However, it serves essential functions in the body. The body naturally produces cholesterol to create hormones and carry out various crucial tasks.

The groundbreaking discovery by researchers at the University of Virginia shows that cholesterol, specifically cholesterol generated by brain cells known as astrocytes, plays a pivotal role in Alzheimer’s disease.

These astrocytes produce and distribute cholesterol to neurons in the brain. This cholesterol buildup in neurons leads to increased production of amyloid beta, a sticky protein that forms the problematic plaques seen in Alzheimer’s patients.

Astrocytes’ Role Unveiled

The study also brings to light the role of astrocytes in Alzheimer’s. Scientists have long observed significant changes in these brain cells during the course of the disease.

Yet, it remained uncertain whether these changes indicated astrocytes were suffering from Alzheimer’s or actively contributing to its progression. The new findings suggest that astrocytes are indeed involved in driving Alzheimer’s disease.

The Cholesterol-Amyloid Beta Connection

In healthy conditions, cholesterol levels are kept low within neurons, preventing excessive amyloid beta buildup. However, in Alzheimer’s disease, neurons lose their ability to regulate amyloid beta production, leading to plaque formation.

The research team conducted experiments in laboratory mice and found that blocking the cholesterol production in astrocytes significantly reduced amyloid beta production.

While the feasibility of replicating this in humans requires further investigation, it represents a promising avenue for potential prevention.

Balancing Act: Amyloid Beta’s Role

The tightly regulated production of amyloid beta suggests that it may serve a vital function in brain cells. This poses a challenge for doctors attempting to block or remove it completely.

Further research into this discovery could provide insights into preventing the overproduction of amyloid beta as a strategy against Alzheimer’s.

Conclusion

Understanding the role of cholesterol, specifically its production by astrocytes, in Alzheimer’s disease marks a significant breakthrough.

It not only elucidates why genes associated with cholesterol have been linked to increased Alzheimer’s risk but also offers a potential avenue for prevention.

Preventing the formation of amyloid beta plaques before memory problems occur could be a game-changer in the fight against Alzheimer’s.

By targeting cholesterol production in astrocytes, researchers hope to halt the progression of the disease before it takes a toll on countless neurons.

While there is much more to learn, this discovery represents a promising step towards a future where Alzheimer’s disease can be effectively managed and potentially prevented.

The research was published in the Proceedings of the National Academy of Sciences.

If you care about Alzheimer’s, please read studies about the likely cause of Alzheimer’s disease and new non-drug treatment that could help prevent Alzheimer’s.

For more information about brain health, please see recent studies about diet that may help prevent Alzheimer’s, and results showing some dementia cases could be prevented by changing these 12 things.

The research findings can be found in PNAS.

Copyright © 2023 Knowridge Science Report. All rights reserved.